Ex Vivo Evaluation of Antiangiogenic Drugs in Oral Cancer: Potential Implications for Targeting Vasculogenic Mimicry. Hujanen R, Salo T, Eklund KK, Salem A, et al. Anticancer Res 2024;44:2377-2392.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hujanen R, Salo T, Eklund KK, Salem A, et al. Ex Vivo Evaluation of Antiangiogenic Drugs in Oral Cancer: Potential Implications for Targeting Vasculogenic Mimicry. Anticancer Res 2024;44:2377-2392.
PMID: 38821582